Popular on EntSun
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 227
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV - 173
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research - 134
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits - 126
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide - 119
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market - 119
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) - 117
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence - 113
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations - 107
- The Sessions Studios Secures $300 Million Commitment to Launch World-Class Studio and 15-Film Global Slate - 106
Similar on EntSun
- Pixel Studio Productions Launches Same-Day Headshots in Houston
- SeedList Launching Institutional Crypto Crowdfunding Project to Empower Retail Investors and Disrupt the VC-Dominated Crypto Fundraising Landscape
- Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
- databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
- AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
- WonderDays Launches the UK's First AI Experience Gift Finder – Gifting Just Got So Much Easier!
- CelluHeal™ Launches Full Line of Advanced Wound Dressings for Online Purchase in the USA, Canada, and Beyond
- Nonprofit innovator named Mensa Executive Director
- Yasmine Roulleau named Managing Director in Vancouver, Canada
Metavivor Announces 2019 Grant Awards For Metastatic Breast Cancer Research
EntSun News/10803465
METAvivor Research and Support announces 32 new grant awards for metastatic breast cancer research totaling $5,000,000. This banner year for grant awards is a result of increasing awareness of metastatic breast cancer and the lack of funding for research targeted specifically for metastatic breast cancer. The grants hold promise for future treatments and therapies that will have a significant and positive impact for metastatic breast cancer.
ANNAPOLIS, Md. - EntSun -- METAvivor Research and Support Inc., a non-profit organization dedicated to funding research for stage IV metastatic breast cancer (MBC), announces 32 grant awards totaling $5,000,000. These research grants will enhance the understanding of metastatic breast cancer, help improve current treatments and develop greatly needed therapeutic options to combat this complicated disease. Since its founding in 2009, METAvivor has put 100% of donations into its peer-reviewed research grant program.
Metastatic breast cancer (also known as stage IV or advanced stage cancer) is the spread of breast cancer to other parts of the body -- most commonly to the bones, liver, lungs and/or brain. Approximately 30% of breast cancer patients metastasize, with the mean survival after diagnosis being 33 months. In the US, only 2-5% of all cancer research funds are dedicated to Stage IV cancer research – yet 98% of all breast cancer deaths are caused by a metastasis.
"2019 was METAvivor's 10-year anniversary and we set a goal to have our biggest grant funding cycle." said Beth Fairchild, President of the Board of Directors "We exceeded our goal with the help of our committed supporters and fundraisers. We have to continue to increase funding for metastatic breast cancer or we will continue to lose lives to metastatic breast cancer"
METAvivor is awarding grants from four award programs. The Early Career Investigator Award program is focused on funding grants for early career metastatic breast cancer researchers, The Translational Research Grant awards program is targeted at career metastasis researchers with a total award of up to $200,000 per grant for 2019, a $100,000 Advisor's Award and the Founder's Award of $500,000 is a special grant category focused on clinical research.
METAvivor is pleased to present the grants based on funds from our donors and fundraisers who have helped METAvivor to achieve and exceed its challenge goal for 2019.
Beth Fairchild, President of METAvivor, said, "The 32 grants that we are presenting today, bring our grand total of metastatic breast cancer specific research awards to $12,400,000. It is our sincere hope that these grants, and the vital research that they fund, will move us closer to fulfilling our promise to transform metastatic breast cancer from a terminal disease into a chronic, manageable condition. We would like to thank our donors, fundraisers, research partners, sponsors and the breast cancer community for their ongoing support and commitment."
METAvivor 2019 grant recipients:
METAVIVOR FOUNDERS' AWARD
Presented In Memory of Karen Presswood, Co-Founder of METAvivor - Massimo Cristofanilli, MD, Northwestern University – "Unravelling New Cytokine-Mediated Mechanisms to Enhance Response to CDK4/6 inhibition in ER+/HER2-Metastatic Breast Cancer"
More on EntSun News
Presented In Memory of Avis Halberstadt, Co-Founder of Metavivor - Andrew Ewald, PhD, Johns Hopkins University, School of Medicine – "Targeting the survival pathways required by established breast cancer metastases"
Presented In Memory of Rhonda Rhodes, Co-Founder of Metavivor - Carol Lange, PhD, University of Minnesota – "Targeting Activated Progesterone Receptors in Metastatic Breast Cancer"
METAVIVOR EARLY CAREER INVESTIGATOR AWARDS
Erin Remme, Minneapolis Metsquerade Presents - Prasanna Alluri, MD, PhD, UT Southwestern Medical Center at Dallas – "Identifying Therapeutic Vulnerabilities in RB1-negative, ER-positive Breast Cancers"
2019 New York Fashion Week Presents, In Honor of Chiara D'Agostino - Lucia Borriello. PhD, Albert Einstein College of Medicine- "Targeting the Mechanism of Re-Dissemination and Metastasis in Stage IV Breast Cancer"
METAvivors of New Jersey Presents - Joshua Drago, MD, Memorial Sloan Kettering Cancer Center – "The intestinal microbiome and response to chemoimmunotherapy in patients with metastatic triple negative breast cancer (MTNBC)"
Presented In Memory of Kristin Todd - Mick Edmonds, PhD, MS, UAB School of Medicine – "A novel strategy targeting SRC tyrosine kinase for breast cancer metastasis"
Northwest Arkansas Metsquerade Presented In Memory of Angie Powell - Colt Egelston, PhD, City of Hope – "Bispecific monoclonal antibodies for treatment of advanced breast cancer"
Triangle Metsquerade Presented In Memory of Kristie Godwin Rolan - Jeremy Force DO, MA, Duke University – "Discovery and validation of putative oncogenic ROS1 alterations in breast cancer"
Abbey Rapoport Presents - Jamie Fornetti, BA, PhD, Huntsman Cancer Institute, University of Utah - "Novel RON Inhibitors for the Treatment of Metastatic Breast Cancer"
2019 New York Fashion Week Presented In Honor of Michael Kovarik - Antonio Giordano, MD, PhD - Medical University of South Carolina - "Phase 1 clinical trial of Polo-like kinase 1 inhibition with nab-paclitaxel in TP53 mutated metastatic triple negative breast cancer"
2019 METAbash Presents - Sheheryar Kabraji, BMBCh, Dana-Farber Cancer Institute – "Targeting drug-resistant quiescent cancer cells in breast cancer brain metastases"
Jungwoo Lee, PhD, University of Massachusetts Amherst - "Tissue-engineered bone to determine the impact of chemotherapy-induced premature aging in breast tumor metastasis"
Erin Remme, Minneapolis Metsquerade Presents - Michael Lukey PhD, Cornell University – "Targeting the unique metabolic profile of brain metastases in breast cancer"
Miles4Metavivor Presented In Memory of Connie Cadwell - Ashley Makela, PhD - The Institute for Quantitative Health Science and Engineering, Michigan State University - "Understanding extracellular vesicle trafficking in established breast cancer metastases: In vivo tri-modal imaging provides longitudinal and quantitative information on accumulation in metastatic sites"
METAribbon Challengers Present - Madeline Oudin, BSc, MSc, PhD, Tufts University – "Investigating how obesity-driven changes in the tumor microenvironment promote metastatic outgrowth and chemoresistance in metastatic TNBC
Presented In Memory of Rebecca McNally Gilden - Blessed mother, wife, daughter, engineer, friend and breast cancer advocate - Lijuan Sun, PhD, Cold Spring Harbor Laboratory – "Reprogramming innate-adaptive immune interactions to eliminate metastatic breast cancer "
More on EntSun News
METAVIVOR ADVISORS AWARDS
Northwest Arkansas Metsquerade Presented In Memory of Wendy Taylor - Stuart Martin, PhD, University of Maryland School of Medicine – "Reducing the risk of chemotherapy-induced scattering of metastatic triple-negative breast tumors"
Northwest Arkansas Metsquerade Presented In Memory of Valerie Wright - Danny Welch, PhD, University of Kansas Medical Center University of Kansas Cancer Center – "New inhibitors of breast cancer metastasis"
METAVIVOR TRANSLATIONAL RESEARCH AWARDS
Andrei Bakin, PhD, Roswell Park Cancer Center – "A Novel Combination Therapy to Improve Treatment of Metastatic Breast Cancer"
Sanchita Bhatnagar, PhD, University of Virginia School of Medicine - "Targeting the mechanisms of oncogenic TRIM37 in metastatic triple negative breast cancer"
Rolf Brekken, PhD, UT Southwestern – "Pleiotrophin as a driver of the immune metastatic niche"
Minneapolis Metsquerade Presented In Memory of Tarah Harvey - Andrew Brenner, MD, PhD, Mays Cancer Center – "Permeability of Sacituzumab Govitecan in Breast Cancer Brain Metastases"
Orlando Metsquerade Presented In Memory of Destiny Rivera and Stephanie Sunday, Barbara Fingleton, PhD, Vanderbilt University - "Tumor targeting of an immune super-activator in male and female metastatic breast cancer"
Southwest Florida Metsquerade Presented In Memory of Amanda De Fiebre, Barry Hudson, PhD, University of Miami – "Therapeutic targeting of RAGE in metastatic breast cancer"
Fraternal Order of Eagles Presents, Yibin Kang, PhD, Princeton University – "Preventing Regulatory T cell Induction to Enhance Immunity Against Breast Cancer Metastases"
Stephen Kron, MD, PhD, The University of Chicago - "Mechanisms determining local and systemic anti-tumor immune response after metastasis-directed image-guided radiation combined with PD-1/PD-L1 checkpoint blockade"
Chicago Metsquerade Presented In Memory of Lauren Smoke - Sandra McAllister, PhD, Brigham and Women's Hospital; Harvard Medical School – "A new approach to identifying effective therapeutic strategies that eliminate de novo and recurrent stage IV triple-negative breast cancer"
Yusuke Shiozawa, MD, PhD, Wake Forest University – "An osteolytic bone lesion-targeted radiopharmaceutical for bone metastatic breast cancer"
METAvivor Facebook Fundraisers Presents - Zena Werb, PhD, University of California, San Francisco – "Identification of Novel Cell Targets for Metastatic Breast Cancer Therapy"
Jing Yang, PhD, University of California, San Diego – "Overcoming therapy resistance in TNBC metastases through targeted inhibition of Periostin"
ABOUT METAVIVOR
METAvivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009. The organization's main focus is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC. Since 2009, METAvivor has awarded 100 research grants totaling $12.4 million. METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.
METAvivor also raises awareness of MBC, provides support for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community. METAvivor has gained a rapidly growing following within the breast cancer community, and has become a leader in its field.
Visit us at www.METAvivor.org, and follow us on Facebook, Twitter and Instagram.
Metastatic breast cancer (also known as stage IV or advanced stage cancer) is the spread of breast cancer to other parts of the body -- most commonly to the bones, liver, lungs and/or brain. Approximately 30% of breast cancer patients metastasize, with the mean survival after diagnosis being 33 months. In the US, only 2-5% of all cancer research funds are dedicated to Stage IV cancer research – yet 98% of all breast cancer deaths are caused by a metastasis.
"2019 was METAvivor's 10-year anniversary and we set a goal to have our biggest grant funding cycle." said Beth Fairchild, President of the Board of Directors "We exceeded our goal with the help of our committed supporters and fundraisers. We have to continue to increase funding for metastatic breast cancer or we will continue to lose lives to metastatic breast cancer"
METAvivor is awarding grants from four award programs. The Early Career Investigator Award program is focused on funding grants for early career metastatic breast cancer researchers, The Translational Research Grant awards program is targeted at career metastasis researchers with a total award of up to $200,000 per grant for 2019, a $100,000 Advisor's Award and the Founder's Award of $500,000 is a special grant category focused on clinical research.
METAvivor is pleased to present the grants based on funds from our donors and fundraisers who have helped METAvivor to achieve and exceed its challenge goal for 2019.
Beth Fairchild, President of METAvivor, said, "The 32 grants that we are presenting today, bring our grand total of metastatic breast cancer specific research awards to $12,400,000. It is our sincere hope that these grants, and the vital research that they fund, will move us closer to fulfilling our promise to transform metastatic breast cancer from a terminal disease into a chronic, manageable condition. We would like to thank our donors, fundraisers, research partners, sponsors and the breast cancer community for their ongoing support and commitment."
METAvivor 2019 grant recipients:
METAVIVOR FOUNDERS' AWARD
Presented In Memory of Karen Presswood, Co-Founder of METAvivor - Massimo Cristofanilli, MD, Northwestern University – "Unravelling New Cytokine-Mediated Mechanisms to Enhance Response to CDK4/6 inhibition in ER+/HER2-Metastatic Breast Cancer"
More on EntSun News
- California Family Launches Billboard to Reach "Pardon Czar" Alice Marie Johnson
- Performance Slots Available: Collision Course Concert Series Heads to Atlanta, Tampa & Brooklyn
- Rent Like A Champion Acquires CollegeWeekends
- Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
Presented In Memory of Avis Halberstadt, Co-Founder of Metavivor - Andrew Ewald, PhD, Johns Hopkins University, School of Medicine – "Targeting the survival pathways required by established breast cancer metastases"
Presented In Memory of Rhonda Rhodes, Co-Founder of Metavivor - Carol Lange, PhD, University of Minnesota – "Targeting Activated Progesterone Receptors in Metastatic Breast Cancer"
METAVIVOR EARLY CAREER INVESTIGATOR AWARDS
Erin Remme, Minneapolis Metsquerade Presents - Prasanna Alluri, MD, PhD, UT Southwestern Medical Center at Dallas – "Identifying Therapeutic Vulnerabilities in RB1-negative, ER-positive Breast Cancers"
2019 New York Fashion Week Presents, In Honor of Chiara D'Agostino - Lucia Borriello. PhD, Albert Einstein College of Medicine- "Targeting the Mechanism of Re-Dissemination and Metastasis in Stage IV Breast Cancer"
METAvivors of New Jersey Presents - Joshua Drago, MD, Memorial Sloan Kettering Cancer Center – "The intestinal microbiome and response to chemoimmunotherapy in patients with metastatic triple negative breast cancer (MTNBC)"
Presented In Memory of Kristin Todd - Mick Edmonds, PhD, MS, UAB School of Medicine – "A novel strategy targeting SRC tyrosine kinase for breast cancer metastasis"
Northwest Arkansas Metsquerade Presented In Memory of Angie Powell - Colt Egelston, PhD, City of Hope – "Bispecific monoclonal antibodies for treatment of advanced breast cancer"
Triangle Metsquerade Presented In Memory of Kristie Godwin Rolan - Jeremy Force DO, MA, Duke University – "Discovery and validation of putative oncogenic ROS1 alterations in breast cancer"
Abbey Rapoport Presents - Jamie Fornetti, BA, PhD, Huntsman Cancer Institute, University of Utah - "Novel RON Inhibitors for the Treatment of Metastatic Breast Cancer"
2019 New York Fashion Week Presented In Honor of Michael Kovarik - Antonio Giordano, MD, PhD - Medical University of South Carolina - "Phase 1 clinical trial of Polo-like kinase 1 inhibition with nab-paclitaxel in TP53 mutated metastatic triple negative breast cancer"
2019 METAbash Presents - Sheheryar Kabraji, BMBCh, Dana-Farber Cancer Institute – "Targeting drug-resistant quiescent cancer cells in breast cancer brain metastases"
Jungwoo Lee, PhD, University of Massachusetts Amherst - "Tissue-engineered bone to determine the impact of chemotherapy-induced premature aging in breast tumor metastasis"
Erin Remme, Minneapolis Metsquerade Presents - Michael Lukey PhD, Cornell University – "Targeting the unique metabolic profile of brain metastases in breast cancer"
Miles4Metavivor Presented In Memory of Connie Cadwell - Ashley Makela, PhD - The Institute for Quantitative Health Science and Engineering, Michigan State University - "Understanding extracellular vesicle trafficking in established breast cancer metastases: In vivo tri-modal imaging provides longitudinal and quantitative information on accumulation in metastatic sites"
METAribbon Challengers Present - Madeline Oudin, BSc, MSc, PhD, Tufts University – "Investigating how obesity-driven changes in the tumor microenvironment promote metastatic outgrowth and chemoresistance in metastatic TNBC
Presented In Memory of Rebecca McNally Gilden - Blessed mother, wife, daughter, engineer, friend and breast cancer advocate - Lijuan Sun, PhD, Cold Spring Harbor Laboratory – "Reprogramming innate-adaptive immune interactions to eliminate metastatic breast cancer "
More on EntSun News
- databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
- AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
- The Recording Academy Extends Invitation to The World's No.1 Superstar™—But He's Not Chasing the Award
- WonderDays Launches the UK's First AI Experience Gift Finder – Gifting Just Got So Much Easier!
- CelluHeal™ Launches Full Line of Advanced Wound Dressings for Online Purchase in the USA, Canada, and Beyond
METAVIVOR ADVISORS AWARDS
Northwest Arkansas Metsquerade Presented In Memory of Wendy Taylor - Stuart Martin, PhD, University of Maryland School of Medicine – "Reducing the risk of chemotherapy-induced scattering of metastatic triple-negative breast tumors"
Northwest Arkansas Metsquerade Presented In Memory of Valerie Wright - Danny Welch, PhD, University of Kansas Medical Center University of Kansas Cancer Center – "New inhibitors of breast cancer metastasis"
METAVIVOR TRANSLATIONAL RESEARCH AWARDS
Andrei Bakin, PhD, Roswell Park Cancer Center – "A Novel Combination Therapy to Improve Treatment of Metastatic Breast Cancer"
Sanchita Bhatnagar, PhD, University of Virginia School of Medicine - "Targeting the mechanisms of oncogenic TRIM37 in metastatic triple negative breast cancer"
Rolf Brekken, PhD, UT Southwestern – "Pleiotrophin as a driver of the immune metastatic niche"
Minneapolis Metsquerade Presented In Memory of Tarah Harvey - Andrew Brenner, MD, PhD, Mays Cancer Center – "Permeability of Sacituzumab Govitecan in Breast Cancer Brain Metastases"
Orlando Metsquerade Presented In Memory of Destiny Rivera and Stephanie Sunday, Barbara Fingleton, PhD, Vanderbilt University - "Tumor targeting of an immune super-activator in male and female metastatic breast cancer"
Southwest Florida Metsquerade Presented In Memory of Amanda De Fiebre, Barry Hudson, PhD, University of Miami – "Therapeutic targeting of RAGE in metastatic breast cancer"
Fraternal Order of Eagles Presents, Yibin Kang, PhD, Princeton University – "Preventing Regulatory T cell Induction to Enhance Immunity Against Breast Cancer Metastases"
Stephen Kron, MD, PhD, The University of Chicago - "Mechanisms determining local and systemic anti-tumor immune response after metastasis-directed image-guided radiation combined with PD-1/PD-L1 checkpoint blockade"
Chicago Metsquerade Presented In Memory of Lauren Smoke - Sandra McAllister, PhD, Brigham and Women's Hospital; Harvard Medical School – "A new approach to identifying effective therapeutic strategies that eliminate de novo and recurrent stage IV triple-negative breast cancer"
Yusuke Shiozawa, MD, PhD, Wake Forest University – "An osteolytic bone lesion-targeted radiopharmaceutical for bone metastatic breast cancer"
METAvivor Facebook Fundraisers Presents - Zena Werb, PhD, University of California, San Francisco – "Identification of Novel Cell Targets for Metastatic Breast Cancer Therapy"
Jing Yang, PhD, University of California, San Diego – "Overcoming therapy resistance in TNBC metastases through targeted inhibition of Periostin"
ABOUT METAVIVOR
METAvivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009. The organization's main focus is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC. Since 2009, METAvivor has awarded 100 research grants totaling $12.4 million. METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.
METAvivor also raises awareness of MBC, provides support for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community. METAvivor has gained a rapidly growing following within the breast cancer community, and has become a leader in its field.
Visit us at www.METAvivor.org, and follow us on Facebook, Twitter and Instagram.
Source: METAvivor Research and Support, Inc
0 Comments
Latest on EntSun News
- Opteamix Launches StackRewrite.AI to Transform Enterprise Legacy Modernization
- Planet Maldek: Watcher Files Unseals Explosive New Theory About Mars' True Origins
- DatsJustice Ignites the Industry with New Single "Dead Or Alive" & Announces 2025 Tour Kickoff
- "The Pornified Generation": Dr. Chris Samuels Exposes the Toxic Alliance Between Bro Culture and Pornography That's Rewiring a Generation
- Meet a Scientologist Builds Aussie Dreams with Mike and Jonny Hibbard
- Overwhelmed: Rick Denzien's Stark and Stirring Climate Anthem
- The 2025 ESPY Awards After Party- Presented by Poppi & High Noon
- The Modern Insurance Store Expands Medicare Help Services for Seniors in Cincinnati
- Ironside HR Named Fastest-Growing Staffing Firm for Second Year
- Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
- Sing For Your Supper: A Night of Musical Comedy and Drag for a Great Cause
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $100 to $200 Million Equity Agreement with Top Digital Advisor Bitwise to Power Major Digital Asset Initiative for Bitcoin and Solana: OFA Group
- InSpired Brings World Premiere to the Weinberg Center This October
- New Collaboration Launches Corporate ESG Solution for Responsible Decommissioning and Transparent Reporting
- SlickCashLoan Launches Free Loan Calculator to Help You Plan Monthly Payments
- Hot New Fantasy Series Alert: The Key to Wonderland Captivates Readers with Dark Magic and Twisted Romance